Murray-Calloway County Public Hospital Corporation

Murray-Calloway County Public Hospital Corporation was paid $29.54M by Medicaid between Jan 2018 and Dec 2024, across 279 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	96,245	$4.06M
2019	98,305	$3.79M
2020	85,311	$3.42M
2021	106,226	$4.70M
2022	121,846	$4.54M
2023	121,668	$4.84M
2024incomplete	97,757	$4.18M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	17%	21,284	16,566	$5.14M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	11%	10,577	6,653	$3.35M
74177	Computed tomography, abdomen and pelvis; with contrast material	8.3%	5,131	3,871	$2.46M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.5%	13,822	12,175	$2.22M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.3%	14,721	10,073	$1.28M
74176	Computed tomography, abdomen and pelvis; without contrast material	3.1%	2,399	1,758	$913K
70450	Computed tomography, head or brain; without contrast material	3.0%	4,562	3,286	$878K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.7%	22,544	5,790	$806K
96375	Therapeutic injection; each additional sequential IV push	2.5%	12,137	8,585	$726K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.3%	1,733	1,510	$684K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.2%	10,297	4,197	$658K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.8%	2,332	1,462	$542K

267 more codes

71045	Radiologic examination, chest; single view	1.3%	9,622	$378K
80053	Comprehensive metabolic panel	1.3%	51,273	$377K
G0378	Hospital observation service, per hour	1.3%	6,479	$371K
71046	Radiologic examination, chest; 2 views	1.1%	6,491	$327K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	7,919	$292K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	9,856	$286K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	45,555	$277K
59025	Fetal non-stress test	<1%	2,313	$261K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,424	$259K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	493	$239K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,984	$236K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	3,014	$215K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	908	$205K
36415	Collection of venous blood by venipuncture	<1%	56,343	$198K
96361	Intravenous infusion, hydration; each additional hour	<1%	6,564	$183K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	610	$183K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	3,776	$179K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	10,009	$176K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,818	$173K
71275	Computed tomographic angiography, chest, with contrast material	<1%	654	$171K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,218	$167K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	5,775	$159K
97161		<1%	2,815	$145K
84443	Thyroid stimulating hormone (TSH)	<1%	9,671	$131K
96376		<1%	3,612	$129K
97803		<1%	3,507	$124K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,160	$110K
76830	Ultrasound, transvaginal	<1%	786	$107K
72125	Computed tomography, cervical spine; without contrast material	<1%	521	$105K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	315	$102K
36600		<1%	6,105	$102K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	739	$90K
80061	Lipid panel	<1%	6,620	$82K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,402	$81K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,523	$79K
73630		<1%	1,325	$75K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	2,233	$72K
73610		<1%	1,120	$70K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	1,092	$68K
73562		<1%	1,316	$67K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	124	$64K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,369	$64K
74018		<1%	1,135	$58K
43248		<1%	290	$55K
82607		<1%	4,206	$53K
72110		<1%	453	$51K
87400		<1%	3,863	$51K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,419	$51K
93017		<1%	291	$48K
97162		<1%	898	$48K
58661		<1%	21	$47K
73030		<1%	824	$47K
80305		<1%	7,157	$46K
J2704	Injection, propofol, 10 mg	<1%	9,698	$46K
84702		<1%	3,754	$46K
84484		<1%	6,004	$43K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	313	$42K
94060		<1%	446	$40K
73130		<1%	752	$40K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,203	$39K
82803		<1%	3,876	$39K
87086	Culture, bacterial; quantitative colony count, urine	<1%	7,316	$38K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,709	$38K
86900		<1%	2,213	$38K
82746		<1%	2,898	$35K
47563		<1%	12	$35K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	393	$35K
83735		<1%	7,751	$35K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	113	$34K
97164		<1%	1,070	$33K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	4,174	$32K
97802		<1%	411	$32K
86140		<1%	12,286	$31K
84439		<1%	3,882	$31K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	17,649	$31K
58558		<1%	30	$31K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,209	$29K
83690		<1%	7,470	$28K
82728		<1%	2,437	$28K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,035	$27K
78227		<1%	85	$27K
87077		<1%	4,977	$27K
96367		<1%	790	$26K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,203	$25K
83880		<1%	1,318	$24K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,530	$24K
J7050	Infusion, normal saline solution, 250 cc	<1%	2,765	$23K
81025		<1%	6,226	$23K
81001		<1%	11,463	$23K
84403		<1%	1,006	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	8,384	$22K
85027		<1%	4,545	$21K
86803		<1%	1,716	$21K
88304		<1%	761	$20K
70486		<1%	70	$19K
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,795	$19K
73110		<1%	311	$18K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	6,671	$18K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	570	$18K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	394	$17K
87081		<1%	4,096	$17K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	567	$16K
84703		<1%	3,670	$16K
82948		<1%	3,782	$16K
82150		<1%	4,263	$16K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	2,787	$15K
84425		<1%	728	$15K
81003		<1%	6,717	$14K
72131		<1%	59	$14K
95806		<1%	131	$14K
J2060	Injection, lorazepam, 2 mg	<1%	1,279	$13K
97113		<1%	247	$13K
76641		<1%	142	$13K
83540		<1%	2,410	$13K
87186		<1%	2,222	$13K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,343	$13K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	209	$13K
83655		<1%	1,045	$13K
87040		<1%	1,810	$13K
85379		<1%	2,352	$12K
86328		<1%	369	$12K
72100		<1%	202	$12K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	13	$10K
80320		<1%	766	$10K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	895	$10K
86905		<1%	100	$10K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	37	$10K
95811		<1%	15	$10K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,471	$10K
83605		<1%	1,591	$9K
J0690	Injection, cefazolin sodium, 500 mg	<1%	3,521	$9K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	27	$9K
93225		<1%	140	$9K
85610		<1%	3,269	$8K
87070		<1%	1,642	$8K
88307		<1%	148	$8K
83970		<1%	272	$8K
A9270	Non-covered item or service	<1%	6,770	$8K
83001		<1%	352	$7K
83550		<1%	1,053	$7K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	13	$7K
86850		<1%	1,826	$7K
87506		<1%	56	$7K
80143		<1%	682	$7K
74021		<1%	100	$7K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,002	$7K
80179		<1%	664	$7K
93226		<1%	117	$7K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,078	$6K
85730		<1%	1,742	$6K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	929	$6K
87807		<1%	947	$6K
12001		<1%	102	$6K
73080		<1%	57	$6K
82550		<1%	806	$6K
82570		<1%	1,160	$5K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	14	$5K
86038		<1%	517	$5K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	2,979	$5K
82248		<1%	1,127	$5K
82784		<1%	483	$5K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	405	$5K
83516		<1%	286	$5K
93971		<1%	25	$5K
84481		<1%	302	$5K
74220		<1%	43	$5K
86592		<1%	1,330	$5K
82670		<1%	194	$4K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	13	$4K
80055		<1%	78	$4K
84550		<1%	980	$4K
73221		<1%	12	$3K
75574		<1%	14	$3K
71271		<1%	36	$3K
94726		<1%	82	$3K
84436		<1%	835	$3K
83525		<1%	226	$3K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	343	$3K
85652		<1%	1,323	$3K
84146		<1%	187	$3K
86901		<1%	2,222	$3K
94729		<1%	83	$3K
97035		<1%	250	$3K
76536		<1%	24	$3K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	264	$3K
88112		<1%	69	$3K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	742	$3K
97116		<1%	113	$3K
90715		<1%	189	$3K
87340		<1%	665	$3K
80074		<1%	76	$3K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	15	$3K
86787		<1%	122	$2K
86738		<1%	311	$2K
86757		<1%	90	$2K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,096	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	415	$2K
83921		<1%	205	$2K
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	595	$2K
86762		<1%	456	$2K
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	<1%	104	$2K
87205		<1%	637	$2K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	147	$2K
86618		<1%	109	$2K
86769		<1%	30	$2K
87046		<1%	212	$1K
72050		<1%	17	$1K
J3480	Injection, potassium chloride, per 2 meq	<1%	326	$1K
73502		<1%	43	$1K
J1335	Injection, ertapenem sodium, 500 mg	<1%	32	$1K
72114		<1%	15	$1K
74022		<1%	24	$1K
87324		<1%	169	$1K
86666		<1%	71	$1K
76870		<1%	12	$970.36
82043		<1%	192	$966.39
90714		<1%	126	$932.74
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	58	$922.95
97804		<1%	12	$920.78
87209		<1%	87	$915.07
87427		<1%	105	$914.00
71101		<1%	13	$870.85
86003		<1%	14	$851.61
86308		<1%	240	$797.90
97012		<1%	35	$772.34
82565		<1%	96	$737.00
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	129	$730.02
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	289	$675.01
82378		<1%	31	$623.97
84165		<1%	45	$614.80
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	69	$600.01
87045		<1%	106	$596.69
88302		<1%	24	$594.51
87177		<1%	89	$586.74
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	15	$563.88
82140		<1%	103	$498.90
84520		<1%	65	$474.83
86037		<1%	15	$468.78
J1644	Injection, heparin sodium, per 1000 units	<1%	55	$445.62
86696		<1%	27	$443.10
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	132	$437.45
87329		<1%	88	$420.63
74300		<1%	12	$407.10
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	352	$404.42
86695		<1%	27	$396.09
86671		<1%	14	$325.90
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	94	$294.10
84144		<1%	14	$281.44
88104		<1%	13	$239.06
J1171	Injection, hydromorphone, 0.1 mg	<1%	62	$227.10
82947		<1%	44	$226.45
84156		<1%	71	$204.74
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	22	$170.25
J0780	Injection, prochlorperazine, up to 10 mg	<1%	25	$164.78
86430		<1%	35	$162.76
C1769	Guide wire	<1%	17	$158.09
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	111	$145.65
84100		<1%	34	$136.98
89055		<1%	34	$84.76
83615		<1%	13	$81.37
80329		<1%	76	$51.60
J2470	Injection, pantoprazole sodium, 40 mg	<1%	26	$45.19
80050	General health panel	<1%	18	$44.93
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	52	$33.78
84155		<1%	57	$26.55
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	19	$15.87
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	46	$15.14

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAVISON, KITTY (ARRA COORDINATOR)